Partners Hero
shape-element-one[1]
shape-element-two[1]

Partnering with Ambry

Biopharma, academic, clinical, nonprofit, and health system partners are welcome to join us in advancing knowledge to improve the health of patients.

Common Partnership Types

Medical, glass wall and women in lab with tablet, collaboration and notes for genetic study. Science, support and researcher in clinic with idea board, problem solving and analysis of dna formula.

Biopharmaceutical

For our biopharma partners, Ambry streamlines the therapeutic development process by providing robust analytical and clinical validation . Leveraging a consented real-world database from over 2.5 million genetic tests, we deliver the deeper insights necessary to inform and advance precision medicine.
People, scientist and vial with blood sample for exam, text or experiment for medical research. Woman, man or scientific team with DNA for forensic investigation, diagnosis or genetic analysis in lab

Academia and Research

Ambry accelerates scientific discovery through 100+ active collaborations with top-tier academic institutions, public repositories, and a longstanding commitment to data sharing. Together, we translate vast genomic datasets into peer-reviewed discoveries that collectively advance the field.
Ethnic woman in medical consultation with female doctor

Clinical Teams and Health Systems

The award-winning Ambry CARE program integrates digital health applications into clinical workflows to identify high-risk patients and standardize care. This end-to-end platform streamlines genetic testing and makes result reports, patient educational materials, and post-test genetic counseling accessible in one place.
Web_MedTechAwards_2026
9de0602ad05a5a5b5aa4c14bbcd6c26319d76574 (1)

AmbryLink: No-Cost Testing Programs

AmbryLink is a sponsored testing program available at no cost. It enables biopharmaceutical partners to identify rare disease patients more quickly and accurately, shortening the diagnostic journey for patients. The program maximizes patient identification by bringing together Ambry’s genetic testing, an established network of relationships at major academic centers, and broad field support to lower access barriers.